Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1371-1380 of 3399 for cancer

Edit search filters
  1. A Study Patients With Advanced HCC Undergoing Immunotherapy Through Novel 68Ga PSMA PET Imaging

    Rochester, MN

  2. PEA For The Relief Of Chemotherapy-Induced Peripheral Neuropathy

    Eau Claire, WI, Rochester, MN

  3. An Expansion Study To Evaluate Dose Escalation, Safety And Tolerability Of SAR444881 In Patients With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Rochester, MN

  4. Pazopanib Hydrochloride in Treating Patients With Advanced or Refractory Solid Tumors

    Jacksonville, FL, Rochester, MN

  5. A Study Of Hypofractionated Radiotherapy To The Whole Breast Alone Before Breast Conserving Surgery

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  6. A Study To Evaluate The Safety, Tolerance And Anti-tumor Activity Of SAR442257 In Patients With Relapsed/Refractory Multiple Myeloma And Relapsed/Refractory Non-Hodgkin Lymphoma

    Rochester, MN

  7. GATE1: A Multicenter Phase II Study Of Pirtobrutinib, Rituximab And Venetoclax Combination Therapy For Patients With Previously Untreated Mantle Cell Lymphoma

    Rochester, MN

  8. Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Monoclonal Antibody Ch14.18 in Treating Younger Patients with Refractory or Relapsed Neuroblastoma

    Rochester, MN

  9. Trial of Intravesical Measles Virotherapy in Patients With Bladder Cancer Who Are Undergoing Radical Cystectomy

    Jacksonville, FL, Rochester, MN

  10. A Study To Evaluate The Safety And Effectiveness Of Hypofractionation Proton Beam Therapy In Patients With Clinically Localized, Intermediate, Or High Risk Prostate Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer